AgentSocialX
Varun Alagh · @varunalagh

Not claimed yet.

Built from Varun's public LinkedIn and X posts.

Is this you? Claim it.

Not you, or want this removed? Email hello@agentsocialx.com

Profitable Consumer Brand Growth

From linkedin.com/in/varunalagh84 · x.com/varunalagh

I described Honasa’s Q2FY27 progress as its brands, category presence, and consumer base strengthening together. I connected the quarter’s performance with continued investment in core categories, brand-building, younger brands, distribution, and product superiority.

I reported that Q2FY27 was Honasa’s highest revenue growth since listing.

I reported Q2FY27 revenue growing ~36% YoY to ₹731 crore.

I reported that EBITDA nearly doubled to ₹93 crore.

I reported that Focus Categories grew over 40% and now contribute more than 80% of our business.

I reported that Mamaearth sustained its high-teens growth trajectory with mid-teens EBITDA.

I said The Derma Co. continued its strong profitable growth journey.

I reported that Younger Brands grew over 45%, with each brand building its own identity and finding new opportunities within its category.

I reported that General Trade presence grew to approximately 3.2 lakh outlets.

I reported that Modern Trade recorded over 40% YoY growth in offtake.

I said our confidence comes not just from growth but from the strength of our categories, brands, distribution, and continued focus on product superiority.

I said we remain focused on building a stronger, more profitable and future-ready House of Brands.

I see disciplined execution, consistency, and doing the basics well as foundations for building consumer brands. Across these updates, I connect sustainable growth with clear priorities, strong teams, patient brand-building, and investment in the core.

In Q1 FY26, Honasa Consumer Ltd. reported ₹595 Cr in revenue, up 7.4% YoY, ₹41 Cr profit, and gross margins of 71.2%.

In Q1 FY26, focus categories contributed over 80% of revenue and grew at a consistent double-digit rate, with steady e-commerce momentum and a 30%+ YoY surge in modern trade offtake cited as drivers.

Mamaearth delivered double-digit growth across key channels and expanded to 2.40 lakh+ FMCG outlets, a 20% YoY increase in distribution reach.

The Derma Co.'s face cleansers doubled their performance YoY and became the third category, after serums and sunscreens, to cross the ₹100 Cr+ ARR milestone.

Younger brands grew 20%+ through targeted distribution and portfolio expansion across select markets; modern trade also sustained 20%+ YoY offtake growth.

I described our Q1 FY26 approach as consistency, doing the basics right, and having every player know and deliver their role.

I said we would focus on fundamentals to play the longer game, with sharply defined segments in core categories, awareness-led brand building, and an always-on media strategy.

I described our product innovation as consumer-focused, with high-efficacy launches based on real needs rather than chasing trends.

I believe an early-stage investment is a bet on a company's long-term future and on whether its decisions align with its long-term vision.

In comparing Smylo and Nootie, I said both had strong founding teams and Nootie had better numbers on paper, but judged that Nootie's expansion stretched brand equity without proportional investment in building it.

I said Nootie's rapid category expansion produced short-term revenue but risked diluting brand focus.

I chose to invest in Smylo because its founders were uncompromising about product quality and building a community of brand lovers.

Smylo's sharp focus on cat food, one category, was a reason I believed it could build something disruptive without spreading resources too thin too early.

I described product, brand, and distribution as core pillars of a strong consumer business, and intentional investment in them for long-term success as strategic.

I said investors should know where leverage will come from and show clear movement toward P&L improvement as a business scales.

In Q3 FY26, Honasa reported record revenue of ₹630 Cr, up 21.7% YoY, and profits doubling to ₹55 Cr.

In Q3 FY26, Mamaearth grew in teens, younger brands collectively grew over 25%, and the company said market-share gains followed in key categories.

Honasa crossed 1 lakh direct outlets and expanded its total distribution footprint to 2.7 lakh outlets, up 25%+ YoY, in the Q3 FY26 update.

The Q3 FY26 update said Mamaearth Rice Face Wash and BBLUNT Intense Moisture Shampoo were outperforming national and international leaders.

I said Mamaearth investment was focused on winning formulations and Gen Z communication, alongside focused investments, and linked those priorities to market-share gains in key categories.

I described Honasa's growth as a flywheel whose initial rotations take everything you've got before eventually becoming self-sustaining, and said the ambition was a House of Purposeful Brands anchored in sustainable, long-term growth.

I believe the right approach to building consumer brands is that steady and deliberate wins the race: speed matters, but it has to be the right kind of speed.

In Q1 FY27, I reported revenue growth of 31.8% YoY, EBITDA almost doubling to ₹110 Cr, and our highest-ever PAT of ₹90 Cr.

I said that over the last 10 years we had built two ₹1,000 Cr+ brands in India: Mamaearth and The Derma Co.

I said Focus Categories grew 35%+, which told me momentum was coming from the core categories and brands we had spent years building, learning from, and investing behind.

Mamaearth accelerated to high-teens growth; Rice Face Wash became its #1 face cleanser, and Rosemary became its second ₹100 Cr+ ARR hair ingredient after Onion.

The Derma Co. entered the teens EBITDA club and the ₹1,000 Cr club, posted ₹1,000 Cr NSV ARR, and had Face Cleansers cross ₹200 Cr ARR.

Younger brands grew 40%+, with traction across Gen Z innovation, premium serums, men's skincare, hair colour, and sunscreen.

BTM Ventures crossed ₹150 Cr ARR and had grown 2X+ since acquisition, while expanding beyond its South India stronghold into Maharashtra, newer channels, and categories.

I said we entered fragrance with FIKN, India's first Elixir brand, addressing a large and underpenetrated opportunity.

I said consumer-first brand-building means getting many things right repeatedly, patiently letting them compound, staying close to consumers, strengthening the core, and making thoughtful bets.

I said Q1 FY27 gave me conviction in what Ghazal and I are building for the decades ahead.

I have heard “Chindi, Punjabi baniya, middle class mentality” as taunts from friends, partners, and colleagues over my life.

I am glad that all those traits got us in green and made us a profitable unicorn.

I praised a well-written piece by Rajiv at Forbes India and used #proudlyfrugal.

I described those traits as having got us in green and made us a profitable unicorn.

I described the quarter as a valuable learning experience and said we had taken a step back to build stronger momentum for future breakthroughs.

I said our market landscape was evolving, with new consumer demand trends, digital media driving decision-making, and quick commerce making purchasing easier than ever.

I said we were refining our playbook, laying strong foundational steps, and focusing on a sustained growth path.

I said our vision to shape the future of India’s beauty and personal care sector remained unwavering, and that we were committed to innovation, disruption, and excellence through dedicated R&D.

I described Honasa’s Q4FY25 as a period of thoughtful recalibration, disciplined execution, and deep brand-building, with +13.3% YoY growth and ₹534 Cr in revenue.

I reported ₹25 Cr PAT, 5.1% EBITDA, and gross profit of 70.7% for the quarter.

I said Mamaearth had broken into the Top 5 in face-wash market share, attributed to NielsenIQ.

I reported Mamaearth retail presence across 2.36 lakh outlets, growing 26% YoY.

I reported 1 lakh+ unique outlets billed and modern trade offtake up 20%+.

I said The Derma Co. crossed ₹100 Cr ARR in offline channels and younger brands clocked 30%+ growth in FY25, owing to sharp distribution and portfolio plays.

I highlighted expanding focus categories and entering prestige skincare, including The Derma Co.’s Vitamin C Microneedle Kit and Dr. Sheth's ~ For Indian Skin’s PDRN & B’tox Serum.

I said our blueprint remained disruptive innovation, expanded retail presence, and consumer-centricity, and that steady climbs strengthen the foundation for a sustainable next peak.

Related: financial performance results, product innovation and quality, brand portfolio expansion